Bio-Techne Corp (TECH)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $11.44B
Last updated: Nov 17, 2026 at 11:06 AM ET
Bio-Techne Corp (TECH) Competitors
The companies most similar to Bio-Techne are BridgeBio Pharma (BBIO), TG Therapeutics (TGTX) and Krystal Biotech (KRYS). Bio-Techne trades at 39.6x earnings, against a median of 40.4x for the 5 of these companies with a P/E. By market cap, Bio-Techne ranks 2nd of the 13 companies on this page; BridgeBio Pharma (BBIO) is the largest at $15.25B.
Peer Comparison
TECH's ROIC of 7.7% is above the peer median of -33.0%, and its revenue growth of 4.6% is below the median of 35.6%. It yields 0.44%, while the median peer pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Bio-Techne (TECH) | $11.44B | 39.6x | 9.3x | 14.0% | 7.7% | 4.6% | 0.44% |
| BridgeBio Pharma Inc (BBIO) | $15.25B | N/A | 16.0x | -59.8% | -33.0% | 192.6% | 0.00% |
| TG Therapeutics Inc (TGTX) | $9.75B | 87.2x | 11.1x | 11.8% | 11.0% | 60.7% | 0.00% |
| Krystal Biotech Inc (KRYS) | $9.05B | 40.4x | 18.8x | 47.9% | N/A | 30.2% | 0.00% |
| Summit Therapeutics PLC (SMMT) | $11.32B | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Twist Bioscience Corp (TWST) | $7.40B | N/A | 14.3x | -28.3% | N/A | 27.9% | 0.00% |
| Legend Biotech Corp (LEGN) | $3.39B | 266.5x | 2.3x | -0.0% | N/A | 32.0% | 0.00% |
| Praxis Precision Medicines Inc (PRAX) | $9.17B | N/A | N/A | 0.0% | N/A | 1349.0% | 0.00% |
| Spyre Therapeutics Inc. (SYRE) | $9.88B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Protagonist Therapeutics Inc (PTGX) | $8.55B | 27.7x | 15.8x | 62.0% | N/A | 5724.0% | 0.00% |
| Halozyme Therapeutics Inc (HALO) | $11.43B | 17.8x | 6.1x | 26.9% | 15.8% | 39.2% | 0.00% |
| Cytokinetics Inc (CYTK) | $7.82B | N/A | 65.3x | 0.0% | -66.0% | 2357.0% | 0.00% |
| Cogent Biosciences Inc (COGT) | $4.97B | N/A | N/A | 0.0% | -43.4% | -100.0% | 0.00% |
| Peer median | $9.11B | 40.4x | 15.0x | 0.0% | -33.0% | 35.6% | 0.00% |
Similar Companies
These are the 12 companies most similar to Bio-Techne, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| BridgeBio Pharma Inc (BBIO) | BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases. | BBIO competitors |
| TG Therapeutics Inc (TGTX) | TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development... | TGTX competitors |
| Krystal Biotech Inc (KRYS) | Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United... | KRYS competitors |
| Summit Therapeutics PLC (SMMT) | Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and markets drugs to treat infectious diseases in the United States, Latin America... | SMMT competitors |
| Twist Bioscience Corp (TWST) | Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. | TWST competitors |
| Legend Biotech Corp (LEGN) | Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology... | LEGN competitors |
| Praxis Precision Medicines Inc (PRAX) | Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal... | PRAX competitors |
| Spyre Therapeutics Inc. (SYRE) | Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by... | SYRE competitors |
| Protagonist Therapeutics Inc (PTGX) | Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical... | PTGX competitors |
| Halozyme Therapeutics Inc (HALO) | Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. | HALO competitors |
| Cytokinetics Inc (CYTK) | Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering... | CYTK competitors |
| Cogent Biosciences Inc (COGT) | Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases. | COGT competitors |
Frequently Asked Questions About TECH
Who are Bio-Techne's main competitors?
The companies most similar to Bio-Techne include BridgeBio Pharma (BBIO), TG Therapeutics (TGTX), Krystal Biotech (KRYS), Summit Therapeutics (SMMT) and Twist Bioscience (TWST), listed from the closest match.
Who is Bio-Techne's biggest competitor?
BridgeBio Pharma (BBIO) is both the largest of the similar companies at $15.25B and the closest match by business profile, size, sector and industry.
How does TECH stock compare with its competitors?
TECH's P/E is 39.6x against a peer median of 40.4x; its P/S is 9.3x against a peer median of 15.0x; its net margin is 14.0% against a peer median of 0.0%.
Which of Bio-Techne's competitors pays a higher dividend?
Bio-Techne has a forward dividend yield of 0.44%. None of the similar companies with available yields has a higher forward dividend yield.
Is Bio-Techne bigger than its competitors?
No. Bio-Techne is 2nd by market cap among the 13 companies on this page; the largest is BridgeBio Pharma (BBIO) at $15.25B.
TECH pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors